scholarly article | Q13442814 |
P50 | author | Jörgen Möller | Q79193157 |
P2093 | author name string | Ataru Igarashi | |
Rei Goto | |||
Reiko Yoshikawa | |||
Alexandra J Ward | |||
Kiyomi Suwa | |||
P2860 | cites work | Long-term prognosis of patients with acute myocardial infarction in the era of acute revascularization (from the Heart Institute of Japan Acute Myocardial Infarction [HIJAMI] registry). | Q51049258 |
A catalogue of EQ-5D utility weights for chronic diseases among noninstitutionalized community residents in Korea. | Q53069448 | ||
Web-based survey on smoking cessation behaviors of current and former smokers in Japan. | Q53147568 | ||
International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? | Q57227507 | ||
The effect of bronchitis, smoking, and occupation on ventilation | Q76455131 | ||
Systematic review: smoking cessation intervention strategies for adults and adults in special populations | Q33256456 | ||
A discrete-event simulation of smoking-cessation strategies based on varenicline pivotal trial data. | Q33858665 | ||
Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial | Q33897433 | ||
Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial | Q33997418 | ||
Adult mortality attributable to preventable risk factors for non-communicable diseases and injuries in Japan: a comparative risk assessment | Q34145606 | ||
COPD in Japan: the Nippon COPD Epidemiology study | Q34553639 | ||
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. | Q35537270 | ||
Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey | Q36405951 | ||
Dynamic effects of smoking cessation on disease incidence, mortality and quality of life: The role of time since cessation. | Q36494908 | ||
Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial | Q36941156 | ||
Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample | Q37268243 | ||
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. | Q38405712 | ||
Predictors of lapse and relapse to smoking in successful quitters in a varenicline post hoc analysis in Japanese smokers | Q38430668 | ||
Medical care for chronic-phase stroke in Japan | Q39626450 | ||
Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study | Q39659131 | ||
Cost-utility analysis of varenicline, an oral smoking-cessation drug, in Japan | Q39988937 | ||
Development of a screening questionnaire for tobacco/nicotine dependence according to ICD-10, DSM-III-R, and DSM-IV. | Q40812875 | ||
Smoking cessation patterns and predictors of quitting smoking among the Japanese general population: a 1-year follow-up study | Q43240449 | ||
Smoking cessation treatment and outcomes patterns simulation: a new framework for evaluating the potential health and economic impact of smoking cessation interventions | Q43781923 | ||
Late relapse/sustained abstinence among former smokers: a longitudinal study | Q45147754 | ||
Cancer incidence and incidence rates in Japan in 2008: a study of 25 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project | Q46153737 | ||
Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial | Q46241957 | ||
Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers | Q50085911 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P304 | page(s) | 77-87 | |
P577 | publication date | 2016-02-01 | |
P1433 | published in | Applied Health Economics and Health Policy | Q15764758 |
P1476 | title | Cost-Effectiveness Analysis of Smoking Cessation Interventions in Japan Using a Discrete-Event Simulation | |
P478 | volume | 14 |
Q58765273 | Application of discrete event simulation in health care: a systematic review |
Q64111168 | Clinical Efficacy of Telemedicine Compared to Face-to-Face Clinic Visits for Smoking Cessation: Multicenter Open-Label Randomized Controlled Noninferiority Trial |
Q60931942 | Comparing Strategies for Modeling Competing Risks in Discrete-Event Simulations: A Simulation Study and Illustration in Colorectal Cancer |
Q91761819 | Comparing Telemedicine and Face-to-Face Consultation Based on the Standard Smoking Cessation Program for Nicotine Dependence: Protocol for a Randomized Controlled Trial |
Q38689880 | Examining the association of smoking with work productivity and associated costs in Japan. |